Annamaria I.
- Country
- Italy
- Department
- IT10012: Reumatologia
Research Overview
- Evaluation of Secukinumab for Maintenance of Remission in Non-Radiographic Axial Spondyloarthritis: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety of Subcutaneous Guselkumab in Active Psoriatic Arthritis: A Phase 3b Randomized, Double-blind, Placebo-controlled Study
- Efficacy of Ixekizumab Versus Methotrexate in Psoriatic Arthritis Dactylitis: A Multicenter, Randomized Controlled Trial
Data & Insights
Has run more than one trial at 13 of 136 partner sites.
Specializations
Rheumatology Focus
This investigator specializes in treating psoriatic arthritis (PsA) and related inflammatory joint conditions, with particular attention to innovative therapeutic approaches using biological treatments.
- Dactylitis Management in PsA
- Advanced Biological Therapies
- Therapeutic Response Assessment
Notable expertise in ultrasound-based evaluation methods for inflammatory joint conditions.
Spondyloarthritis Expertise
Dedicated to advancing treatment options for patients with non-radiographic axial spondyloarthritis, focusing on long-term disease management and remission maintenance.
- Remission Assessment
- Treatment Optimization
- Disease Monitoring
Specializes in evaluating sustained therapeutic responses in inflammatory spine conditions.
Therapeutic Innovation
The investigator focuses on evaluating novel therapeutic agents for inflammatory arthritis, with particular emphasis on symptom reduction and disease control.
- Biological Treatment Assessment
- Clinical Efficacy Evaluation
- Treatment Response Monitoring
Expertise in assessing advanced therapeutic options for complex rheumatological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.